Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: VGX-1027 To Undergo Additional Testing For RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: FDA Approves Actemra
D Scott Cunningham MD, PhD, MDLinx Rheumatology
From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx
  See all
Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Hsp90β and p130CAS: Novel regulatory factors of MMP-13 expression in human osteoarthritic chondrocytes
Annals of Rheumatic Diseases, 07/09/08
Print     Email This Article     Save in My Library   Free Abstract
Fan Z et al. - This study illustrates the complex regulation of MMP-13 by showing the inhibitory effect of the two cytoplasmic molecules, p130cas and Hsp90β in L-OA chondrocytes.

Methods
  • Study to (i) identify regulators of MMP-13 expression/production in human L-OA chondrocytes, (ii) determine their effect on the expression of other MMPs and the effect of IL-1β on these molecules
  • identification of the L-OA chondrocyte proteins interacting with the MMP-13 promoter AGRE-site was performed by mass spectrometry
  • Hsp90β, p130cas and NMP4 siRNAs were transfected into L-OA chondrocytes and incubated with or w/o IL-1β
  • Gene expression was determined by RT-PCR, MMP-1 and -13 production by ELISA ; signaling pathway activation by Western blotting and ELISA

Results
  • Hsp90β was identified as a protein of the L-OA/AGRE specific complex
  • Silencing p130cas and Hsp90β increased the expression and production of MMP-13
  • sip130cas affected to a lesser extent MMP-1 expression and production; siNMP4 showed no effect
  • MMP-2, -3, -9 and -14 expressions were unaffected
  • Silencing both Hsp90β and p130cas had a significant additive effect on MMP-13, but not MMP-1 expression
  • IL-1β decreased p130cas and Hsp90β expression/production, indicating another pathway by which this cytokine up-regulates MMP expression
  • The IL-1β-triggered signaling pathways responsible for MMP up-regulation were unaffected in the silenced cells

Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.